SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-044266
Filing Date
2020-04-07
Accepted
2020-04-07 18:11:21
Documents
2
Period of Report
2020-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2014134d1_form3.html 3  
1 FORM 3 tm2014134d1_form3.xml 3 4383
2 EXHIBIT 24.1 tm2014134d1_ex24-1.htm EX-24.1 3524
  Complete submission text file 0001104659-20-044266.txt   9627
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3119 PONCE DE LEON UNIT C CORAL GABLES FL 33134
Business Address
Abbhi Sankesh (Reporting) CIK: 0001806887 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 20780651